Expressing support for the designation of July 17, 2024, as "Glioblastoma Awareness Day".

HRES 1203 is a symbolic resolution designating July 17, 2024, as "Glioblastoma Awareness Day." It expresses congressional support for raising public awareness about glioblastoma, a highly aggressive brain cancer with a 6.9% 5-year survival rate and limited treatment options. The resolution encourages greater public understanding of the disease's challenges, honors those affected by it, and urges continued research and collaboration. This is a non-binding awareness measure with no new funding or policy changes.